Benjamin D Gallagher1, Nathalie Moise1, Mytra Haerizadeh1, Siqin Ye1, Vivian Medina1, Ian M Kronish2. 1. Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, New York. 2. Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, New York. Electronic address: ik2293@columbia.edu.
Abstract
BACKGROUND: Medication nonadherence contributes to hospitalizations in recently discharged patients with heart failure (HF). We aimed to test the feasibility of telemonitoring medication adherence in patients with HF. METHODS AND RESULTS: We randomized 40 patients (1:1) hospitalized for HF to 30 days of loop diuretic adherence monitoring with telephonic support or to passive adherence monitoring alone. Eighty-three percent of eligible patients agreed to participate. The median age of patients was 64 years, 25% were female, and 45% were Hispanic. Overall, 67% of patients were nonadherent (percentage of days that the correct number of doses were taken <88%). There were no differences between intervention and passive monitoring group patients, respectively, in adherence (median correct dosing adherence 82% vs 73%; P = .41) or in the proportion readmitted within 30 days (30% vs 20%; P = .72). Eighty-eight percent of patients rated the wireless electronic adherence device as somewhat or very easy to use, and 88% agreed to use it again. CONCLUSIONS: Adherence telemonitoring was acceptable to most patients with HF. Diuretic nonadherence was common even when patients knew they were being monitored. Future studies should assess whether adherence telemonitoring can improve adherence and reduce readmissions among patients with HF.
RCT Entities:
BACKGROUND: Medication nonadherence contributes to hospitalizations in recently discharged patients with heart failure (HF). We aimed to test the feasibility of telemonitoring medication adherence in patients with HF. METHODS AND RESULTS: We randomized 40 patients (1:1) hospitalized for HF to 30 days of loop diuretic adherence monitoring with telephonic support or to passive adherence monitoring alone. Eighty-three percent of eligible patients agreed to participate. The median age of patients was 64 years, 25% were female, and 45% were Hispanic. Overall, 67% of patients were nonadherent (percentage of days that the correct number of doses were taken <88%). There were no differences between intervention and passive monitoring group patients, respectively, in adherence (median correct dosing adherence 82% vs 73%; P = .41) or in the proportion readmitted within 30 days (30% vs 20%; P = .72). Eighty-eight percent of patients rated the wireless electronic adherence device as somewhat or very easy to use, and 88% agreed to use it again. CONCLUSIONS: Adherence telemonitoring was acceptable to most patients with HF. Diuretic nonadherence was common even when patients knew they were being monitored. Future studies should assess whether adherence telemonitoring can improve adherence and reduce readmissions among patients with HF.
Authors: Ashley A Fitzgerald; J David Powers; P Michael Ho; Thomas M Maddox; Pamela N Peterson; Larry A Allen; Frederick A Masoudi; David J Magid; Edward P Havranek Journal: J Card Fail Date: 2011-06-23 Impact factor: 5.712
Authors: Friedrich Koehler; Sebastian Winkler; Michael Schieber; Udo Sechtem; Karl Stangl; Michael Böhm; Herbert Boll; Gert Baumann; Marcus Honold; Kerstin Koehler; Goetz Gelbrich; Bridget-Anne Kirwan; Stefan D Anker Journal: Circulation Date: 2011-03-28 Impact factor: 29.690
Authors: Sally C Inglis; Robyn A Clark; Finlay A McAlister; Jocasta Ball; Christian Lewinter; Damien Cullington; Simon Stewart; John Gf Cleland Journal: Cochrane Database Syst Rev Date: 2010-08-04
Authors: Cynthia Feltner; Christine D Jones; Crystal W Cené; Zhi-Jie Zheng; Carla A Sueta; Emmanuel J L Coker-Schwimmer; Marina Arvanitis; Kathleen N Lohr; Jennifer C Middleton; Daniel E Jonas Journal: Ann Intern Med Date: 2014-06-03 Impact factor: 25.391
Authors: Sarwat I Chaudhry; Jennifer A Mattera; Jeptha P Curtis; John A Spertus; Jeph Herrin; Zhenqiu Lin; Christopher O Phillips; Beth V Hodshon; Lawton S Cooper; Harlan M Krumholz Journal: N Engl J Med Date: 2010-11-16 Impact factor: 91.245
Authors: Ingvild Margreta Morken; Marianne Storm; Jon Arne Søreide; Kristin Hjorthaug Urstad; Bjørg Karlsen; Anne Marie Lunde Husebø Journal: J Med Internet Res Date: 2022-02-15 Impact factor: 7.076
Authors: Sergio Cinza Sanjurjo; Pilar Mazón Ramos; Diego Iglesias Álvarez; Daniel Rey Aldana; Manuel Portela Romero; José R González-Juanatey Journal: Rev Esp Cardiol Date: 2021-07-07 Impact factor: 4.753